Accelerate Drug Development with Integrated Bioanalytical Services

Accelerate Drug Development with Integrated Bioanalytical Solutions

Reliable bioanalytical data is essential for confident decision-making at every stage of drug development. Pharmaron provides comprehensive bioanalytical support across small molecules, biologics, biomarkers, and advanced therapeutic modalities, helping sponsors generate robust, reproducible data to advance programmes faster and with reduced risk.

With global laboratories, harmonised technologies, and specialist scientific teams, Pharmaron delivers end-to-end integrated bioanalytical solutions spanning discovery, non-clinical development, translational research, and clinical studies.

Download the brochure to explore our full capabilities, technologies, and integrated development solutions.

What’s Inside the Pharmaron Bioanalysis Brochure?

Discover how Pharmaron can support your program with:

• Support every stage of development — from discovery and candidate selection through IND-enabling studies and Phase I–III clinical trials.
• Access expertise across all molecule types and modalities, including small molecules, biologics, ADCs, peptides, oligonucleotides, biomarkers, and cell and gene therapies.
• Generate reliable, high-quality data with harmonised workflows, advanced technologies, and experienced scientific teams.
• Overcome complex analytical challenges such as unstable analytes, low sample volumes, difficult matrices, and novel therapeutic modalities.
• Leverage advanced analytical platforms, including LC-MS/MS, HRMS, immunoassays, flow cytometry, PCR, and accelerator mass spectrometry (AMS).
• Accelerate programme timelines through global laboratory capacity, streamlined workflows, and rapid turnaround times.
• Benefit from integrated development expertise by combining bioanalysis with ADME/DMPK, metabolism, synthetic chemistry, and clinical pharmacology support.
• Partner with a proven provider trusted by 18 of the world’s top 20 pharmaceutical companies.
• Reduce development risk with tailored assay strategies designed to support confident decision-making across discovery, preclinical, and clinical programmes.
• Gain worldwide support from a global network of bioanalytical laboratories operating across GCP, GLP, and non-GLP environments.